OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
41 hedge funds and large institutions have $8.79M invested in Orexigen Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $12.1M → $8.79M (-$3.32M)
Holders
41
Holding in Top 10
–
Calls
$394K
Puts
$355K
Top Buyers
| 1 | +$1.97M | |
| 2 | +$418K | |
| 3 | +$83K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$81.6K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$54.2K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$163K | |
| 3 | -$160K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$128K |
| 5 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$100K |